大成生化科技(00809.HK)建议“10并1”合并股份

Core Viewpoint - Dachen Biochemical Technology (00809.HK) announced a proposal for a share consolidation, merging every ten existing shares with a par value of HKD 0.10 into one consolidated share with a par value of HKD 1.00 [1] Group 1 - The board of directors recommends the consolidation of both existing shares and convertible preference shares at the same ratio of ten to one [1] - The consolidation is subject to approval by shareholders at the annual general meeting [1] - Following the consolidation, the trading unit on the Hong Kong Stock Exchange will change from 2,000 existing shares to 10,000 consolidated shares [1]